Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9. - Ontiveros-Padilla L; Hendy DA; Pena ES; Williamson GL; Murphy CT; Lukesh NR; Ashcraft KA; Abraham MA; Landon CD; Staats HF; Abraham SN; Carlock M; et al. (Journal of controlled release : official journal of the Controlled Release Society, 2025)